Literature DB >> 28127706

New insights into the tonifying kidney-yin herbs and formulas for the treatment of osteoporosis.

Jian-Bo He1, Mei-Hui Chen2, Ding-Kun Lin3.   

Abstract

Osteoporosis is characterized by an increasing osseous fragility and fracture resulting from the low mass and deteriorated microarchitecture in the bone tissue. The hormone replacement therapy and alendronate were frequently used to treat osteoporosis as the primary therapeutic strategy, but their adverse effects have severely limited their extensive clinical application, therefore, it is urgent to develop alternative or complementary therapeutic agents for anti-osteoporosis. Interestingly, with more people focusing on the complementary and alternative medicine, traditional Chinese herbs and formulas are being gradually recognized as safe and effective agents in the treatment of osteoporosis. In particular, a notable trend is that increasing studies are making efforts to clarify the anti-osteoporotic effects and mechanism of the tonifying kidney-yin herbs and formulas, a category of agents identified as effective therapy. Therefore, the purpose of this study is to comprehensively review the tonifying kidney-yin herbs and formulas that have been reported in the treatment of osteoporosis as well as how the agents play their roles in detail. This current study not only will advance our understanding of the actions of tonifying kidney-yin herbs and formulas, but also provide new evidence for the clinic use of the tonifying kidney-yin herbs and formulas in the treatment of osteoporosis.

Entities:  

Keywords:  Anti-osteoporosis; Kidney-yin; Osteoporosis; Traditional Chinese formula; Traditional Chinese herb

Mesh:

Substances:

Year:  2017        PMID: 28127706     DOI: 10.1007/s11657-016-0301-4

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  12 in total

1.  The Efficacy and Safety of Traditional Chinese Medicine Tonifying-Shen (Kidney) Principle for Primary Osteoporosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Junquan Liang; Fengyi Wang; Jiajia Huang; Yunxiang Xu; Guizhen Chen
Journal:  Evid Based Complement Alternat Med       Date:  2020-10-06       Impact factor: 2.629

Review 2.  Role of Traditional Chinese Medicine in Bone Regeneration and Osteoporosis.

Authors:  Zhicai Peng; Ronghua Xu; Qinjian You
Journal:  Front Bioeng Biotechnol       Date:  2022-05-31

3.  Wedelolactone Mitigates Parkinsonism Via Alleviating Oxidative Stress and Mitochondrial Dysfunction Through NRF2/SKN-1.

Authors:  Shruti Sharma; Shalini Trivedi; Taruna Pandey; Sachin Ranjan; Mashu Trivedi; Rakesh Pandey
Journal:  Mol Neurobiol       Date:  2020-09-07       Impact factor: 5.590

Review 4.  Prevention and Treatment of Osteoporosis Using Chinese Medicinal Plants: Special Emphasis on Mechanisms of Immune Modulation.

Authors:  Hongyan Zhao; Ning Zhao; Peng Zheng; Xiaohong Xu; Meijie Liu; Dan Luo; Huihui Xu; Dahong Ju
Journal:  J Immunol Res       Date:  2018-02-20       Impact factor: 4.818

5.  Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway.

Authors:  Na Wang; Yukun Li; Ziyi Li; Chang Liu; Peng Xue
Journal:  J Cell Mol Med       Date:  2019-03-25       Impact factor: 5.310

6.  Bioinformatic analysis and experimental identification of blood biomarkers for chronic nonunion.

Authors:  Jingwei Wu; Limin Liu; Huaijian Hu; Zhihua Gao; Shibao Lu
Journal:  J Orthop Surg Res       Date:  2020-06-05       Impact factor: 2.359

7.  Gamabufotalin Inhibits Osteoclastgenesis and Counteracts Estrogen-Deficient Bone Loss in Mice by Suppressing RANKL-Induced NF-κB and ERK/MAPK Pathways.

Authors:  Kaiqiang Sun; Jian Zhu; Yi Deng; Ximing Xu; Fanqi Kong; Xiaofei Sun; Le Huan; Changzhen Ren; Jingchuan Sun; Jiangang Shi
Journal:  Front Pharmacol       Date:  2021-04-23       Impact factor: 5.810

8.  Development of software enabling Chinese medicine-based precision treatment for osteoporosis at the gene and pathway levels.

Authors:  Jinyu Li; Guiyu Feng; Haoyang He; Haolin Wang; Jia Tang; Aiqing Han; Xiaohong Mu; Weifeng Zhu
Journal:  Chin Med       Date:  2022-04-15       Impact factor: 4.546

9.  Combination Therapy of Wuweizi (Schisandrae Chinensis Fructus) and Dexamethasone Alleviated Dexamethasone-Induced Glucocorticoid Osteoporosis in Rats with Idiopathic Pulmonary Fibrosis.

Authors:  Zinan Qin; Siyu Li; Xiaojuan Zhang; Guoxiu Liu; Min Gu; Nan Zhang; Jiao Liu; Zhihong Ji; Keao Li; Yongpeng Han; Huaqiang Zhai
Journal:  Biomed Res Int       Date:  2020-03-19       Impact factor: 3.411

Review 10.  Pharmacological Activities of Psoralidin: A Comprehensive Review of the Molecular Mechanisms of Action.

Authors:  Javad Sharifi-Rad; Senem Kamiloglu; Balakyz Yeskaliyeva; Ahmet Beyatli; Mary Angelia Alfred; Bahare Salehi; Daniela Calina; Anca Oana Docea; Muhammad Imran; Nanjangud Venaktesh Anil Kumar; Maria Eugenia Romero-Román; Alfred Maroyi; Miquel Martorell
Journal:  Front Pharmacol       Date:  2020-10-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.